Interestingly, the expression of RGC32 in cell lines with EGFR-TKI sensitive mutations (HCC-827, NCI-H1650, and NCI-H3255) was lower than that in cell lines with the EGFR T790M mutation (NCI-H1975). This evidence concerns the gene EGFR and hepatocellular carcinoma.